Evaluation of the Bio-Rad Geenius HIV 1/2 Assay as an Alternative to the INNO-LIA HIV 1/2 Assay for Confirmation of HIV Infection
2014; American Society for Microbiology; Volume: 52; Issue: 7 Linguagem: Inglês
10.1128/jcm.01184-14
ISSN1098-660X
AutoresOrna Mor, Fernando Mileguir, Michal Michaeli, Itzchak Levy, Ella Mendelson,
Tópico(s)HIV/AIDS drug development and treatment
ResumoThe Bio-Rad Geenius HIV 1/2 assay was evaluated as an alternative to the INNO-LIA HIV 1/2 assay for the confirmation of HIV infection in 198 serum samples reactive to 4th-generation HIV enzyme immunoassays (EIAs). The Geenius assay correctly identified 85% of the samples, compared to 75% identified by the INNO-LIA assay, reduced the number of indeterminate results, and shortened the overall turnaround time.
Referência(s)